Ironwood Pharmaceuticals | IRWD - PE价格收益



金融业
股票价格
USD
资产
USD 396.06M
现金及等价物
USD 140.41M
销售成本
USD 29.83M
流动资产
USD 273.84M
流动负债
USD 242.5M
债务
USD 583.99M
EBIT
USD 33.22M
EBITDA
USD 81.81M
员工
267
EPS每股收益
USD -0.01
股本和储备
USD -264.16M
销售毛利
USD 85.24M
债务利息支出
USD 8.74M
利息收入
USD 778K
贷款资金
USD 583.99M
市值
USD 731M
净收入
USD 3.19M
营业费用
USD 57.33M
营业利润
USD 33.22M
普通股股本
USD 160K
PE价格收益
204.24
税前利润
USD 68.02M
销售收入
USD 47.71M
销售和管理费用
USD 33.33M
贸易债权人
USD 1.61M
应收帐款人
USD 81.89M


Pe 更改 日
Acadia Pharmaceuticals 11.61 2.09 2025-12
Agios Pharmaceuticals 3.56 0 2026-03
Akebia Therapeutics 1.63K 1.6K 2025-12
Almirall 79.43 0.3 2025-12
Alnylam Pharmaceuticals 80.04 90.66 2026-03
Amarin 91.05 88.3 2023-06
Astellas Pharma 15.48 8.16 2026-03
AstraZeneca 29.59 2.3 2026-03
Charles River Laboratories 43.58 0.86 2025-12
Emergent BioSolutions 14.4 2.25 2022-09
Esperion Therapeutics 129.79 129 2024-12
Halozyme Therapeutics 23.16 7.7 2025-12
Incyte 15.35 0.51 2026-03
Ironwood Pharmaceuticals 204.24 88.19 2024-12
Lexicon Pharmaceuticals 12.44 4.73 2021-06
Moderna 27.22 14.51 2023-06
Pacira 38.58 14.1 2026-03
PTC Therapeutics 9.98 3.25 2025-12
Puma Biotechnology 13.93 44.88 2024-06
Sarepta Therapeutics 27.27 0 2025-09
Takeda 235.05 184.95 2025-12
Vanda Pharmaceuticals 16.79 7.07 2023-06